Investors in Sprout AI continue to face a waiting game. The suspension of trading on the Canadian Securities Exchange (CSE) persists as the company undergoes a significant corporate restructuring. This process centers on a planned reverse takeover by TheraCann International Benchmark Corporation, a move designed to refocus the business on vertical farming solutions.
Regulatory Halt and Strategic Shift
The CSE has officially classified the halt as “pending fundamental change,” a clear indicator of the substantial corporate actions underway. The core transaction involves a merger with TheraCann, a specialist provider of turnkey cultivation systems for controlled environment agriculture. Trading will remain paused until the exchange completes its review procedures and all requisite listing conditions are satisfied.
Although the transaction was considered nearly finalized as far back as July 2025, the resumption of share trading has been delayed. This is due to outstanding formal requirements, including regulatory approval for the necessary “Form 5A” filing.
Should investors sell immediately? Or is it worth buying Sprout AI?
Operational Continuity During the Pause
Despite the standstill in its public market activity, Sprout AI maintains its operational and regulatory obligations. The company announced a strategic partnership with AMISK in January 2026, aimed at advancing solutions for nutrition and energy security. Its reporting duties also continue uninterrupted; the monthly status report for February 2026 was filed on schedule by March 6.
The company’s focus during this period remains on the planning and manufacturing of vertical farming systems, with particular emphasis on its Fogponic technology platform.
Path Forward and Pending Milestones
The timeline for Sprout AI’s return to active trading now hinges primarily on the progress of the regulatory review process. Once the reverse takeover is finalized, strategic planning for the newly combined entity will take center stage. Until that point, official communications confirming the completion of the transaction will serve as the critical signal for all market participants.
Ad
Sprout AI Stock: Buy or Sell?! New Sprout AI Analysis from November 12 delivers the answer:
The latest Sprout AI figures speak for themselves: Urgent action needed for Sprout AI investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 12.
Sprout AI: Buy or sell? Read more here...
